Lithospermoside (Standard)

Overview

Lithospermoside (Griffonin) (Standard) is the analytical standard of Lithospermoside ( HY-N0821 ). This product is intended for research and analytical applications. Lithospermoside is an orally active Na + /K + -ATPase inhibitor and hypoglycemic agent. Lithospermoside increases intracellular sodium levels in normal and sickle red blood cells. Lithospermoside reduces fasting blood glucose levels, improves glucose tolerance, and prevents weight loss in diabetic mice. Lithospermoside can be used in the research of sickle cell disease and diabetes.

Application

Products | Products > Disease Areas > Sickle Cell Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Blood Disease | Products > Disease Areas > Glucose Metabolism | Products > Signaling Pathways > Others | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Na+/K+ ATPase

Product Information

• Catalog No.: HY-N0821R
• CAS No.: 63492-69-3
• Molecular Formula: C14H19NO8
• Molecular Weight: 329.30
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source